Asked by: Greg Smith (Conservative - Mid Buckinghamshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of cancer patients in Mid Buckinghamshire constituency receive first treatment within the 62 day target.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Data is not collected at a constituency level. Data on what proportion of cancer patients in the Buckinghamshire, Oxfordshire and Berkshire West Integrated Care Board received a first treatment within the 62-day cancer waiting time standard can be found on the NHS England website at the following link:
https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of people walking on (a) cancer prevention and (b) cancer recovery.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Being physically active, including walking and brisk walking, can help with the prevention and management of long-term health conditions, such as some cancers. Movement is an important part of care for people going through cancer treatment, helping to support recovery and boosting mental health and wellbeing.
The recently published National Cancer Plan is putting quality of life at the heart of cancer care, including physical activity to help patients through treatment successfully. Every patient will get a personalised plan that looks at their physical, mental, and practical needs, with support increasingly delivered through neighbourhood services and accessible digitally through the NHS App.
Under the plan we will deliver a universal digital-first prehabilitation offer for all cancer patients through the NHS App and other digital channels. This will include signposting to other existing digital services such as exercise classes and walking apps like NHS Active 10, ensuring cancer patients can best prepare for their treatment at, or close to, home.
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of reducing the starting age for routine mammograms to 40.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Each year, over 15 million people are invited for screening by National Health Service screening programmes, with over 10 million taking up the invitation. Through our NHS screening programmes, we can reduce mortality and morbidity from cancer and other conditions in the population who appear healthy and have no symptoms, by detecting conditions at an earlier, more treatable stage.
We are guided by the independent scientific advice of the UK National Screening Committee (UK NSC) on all screening matters. It is only where there is robust evidence that an offer to screen provides more good than harm that a screening programme is recommended.
As screening programmes can also cause harms, each of the adult screening programmes has both an upper and lower age range, within which there is good scientific evidence that the benefits of screening outweigh the harms.
The NHS Breast Screening Programme does not currently offer screening to women younger than the age of 50 for breast cancer due to the lower risk of women under this age developing breast cancer, and the fact that women below 50 tend to have denser breasts tissue. The density of breast tissue reduces the ability of getting an accurate mammogram, the accepted screening test for breast cancer.
There is therefore a risk of unnecessary treatment and distress for women who do not have breast cancer, but who would be subjected to invasive and painful medical treatments and diagnostic tests.
We are in line with most European countries, most of whom screen women between the ages of 50 to 69 years old.
The UK NSC recognises that screening programmes are not static and that, over time, they may need to change to be more effective. Work is underway within the breast screening programme to investigate the possibility of routinely screening below the currently recommended age. The AgeX research trial has been looking at the effectiveness of offering some women one extra screen between the ages of 47 and 49 years old.
It is the biggest trial of its kind ever to be undertaken and will provide robust evidence about the effectiveness of screening in these age groups, including the benefit and harms. The UK NSC will review the publication of the age extension trial when it reports.
Asked by: Adam Dance (Liberal Democrat - Yeovil)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that people over the age of 71 can request a breast cancer screening in Yeovil constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
People in Yeovil who are over the age of 71 years old can request breast cancer screening once every three years by contacting their local National Health Service breast screening programme directly.
They will be offered an appointment at either the nearest mobile screening van, which rotate around the county on a three-yearly cycle, or the static screening centre at Musgrove Park Hospital in Taunton.
Asked by: Laura Kyrke-Smith (Labour - Aylesbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how much funding he plans to provide for treatments for secondary breast cancer in each of the next three years.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available.
Asked by: Sorcha Eastwood (Alliance - Lagan Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what Barnett consequentials arise for Northern Ireland as a result of the £10 million per year funding announced to cover travel costs for children and young people with cancer in England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department knows that the cost of travel is an important issue for many young cancer patients and their families across the United Kingdom.
Through the National Cancer Plan, the Government is committing up to £10 million a year to a new fund open to all children and young people in England with cancer and their families regardless of income, to support them with the cost of travelling to and from Principal Treatment Centres. This commitment sits alongside wider action to transform cancer care for children and young people.
Health is predominately devolved. Devolved administrations receive funding through the Barnett Formula, and it is ultimately for them to allocate, prioritise, and manage their budgets. However, the Department does work closely with our counterparts in the devolved governments to share expertise and identify new opportunities to improve health and social care delivery across the UK.
Asked by: Sorcha Eastwood (Alliance - Lagan Valley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Northern Ireland Department of Health and the Northern Ireland Executive to ensure that families of children and young people with cancer in Northern Ireland can benefit from support comparable to the travel cost scheme announced for England.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department knows that the cost of travel is an important issue for many young cancer patients and their families across the United Kingdom.
Through the National Cancer Plan, the Government is committing up to £10 million a year to a new fund open to all children and young people in England with cancer and their families regardless of income, to support them with the cost of travelling to and from Principal Treatment Centres. This commitment sits alongside wider action to transform cancer care for children and young people.
Health is predominately devolved. Devolved administrations receive funding through the Barnett Formula, and it is ultimately for them to allocate, prioritise, and manage their budgets. However, the Department does work closely with our counterparts in the devolved governments to share expertise and identify new opportunities to improve health and social care delivery across the UK.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce regional inequalities in health outcomes.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
It is a priority for the Government to increase the amount of time people spend in good health and prevent premature deaths, with an ambitious commitment to halve the healthy life expectancy gap between the richest and poorest regions.
We know that everyday life poses greater health risks to the most disadvantaged in society, and that the current model of care works least well for those who already experience disadvantage and are far more likely to have complex needs. To help tackle this, we will distribute National Health Service funding more equally locally, so it is better aligned with health need.
Further to this, much of what determines health and wellbeing is influenced by factors other than health services. As a result, we are taking bold action across the Government on the social determinants of health to build a fairer Britain, where everyone lives well for longer.
Cross-Government activity includes the introduction of Awaab’s Law, ensuring landlords will have to fix significant damp and mould hazards, and legislating for a new statutory health and health inequalities duty for strategic authorities.
We support the NHS’s CORE20PLUS5 approach which targets action to reduce health inequalities in the most deprived 20% of the population and improve outcomes for groups that experience the worst access, experience, and outcomes within the NHS. The approach focuses on improving the five clinical areas at most need of accelerated improvement, namely cardiovascular disease, cancer, respiratory, maternity, and mental health outcomes, in the poorest 20% of the population, along with other disadvantaged population groups identified at a local level.
In addition, we know that the Carr-Hill formula, the United Kingdom’s formula for allocating core funding to general practices (GPs), is considered outdated, and evidence suggests that GPs serving in deprived parts of England receive on average 9.8% less funding per needs adjusted patient than those in less deprived communities, despite having greater health needs and significantly higher patient-to-GP ratios. This is why we are currently reviewing the formula to ensure that resources are targeted where they are most needed.
Asked by: Liam Conlon (Labour - Beckenham and Penge)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the average national unit cost to the NHS is for an MRI scan used in prostate cancer detection using (a) multiparametric and (b) biparametric MRI.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The average cost to the National Health Service for magnetic resonance imaging (MRI) scans using biparametric and multiparametric MRIs is set out in the 2025/26 National Payment Scheme, which can be found at the following link:
https://www.england.nhs.uk/publication/2025-26-nhs-payment-scheme/.
Biparametric MRI scans are categorised under ‘non contrast’, whilst multiparametric MRI scans are categorised ‘with contrast’. The following table shows the price of different MRI scans:
Test type | Test name and description | Price |
MRI | MRI non contrast 1 area (Adult) | £129 |
MRI non contrast 1 area (Paediatric age 6 to18) | £217 | |
MRI non contrast 2 area | £155 | |
MRI non contrast more than 3 area | £222 | |
MRI with contrast 1 area (Adult) | £188 | |
MRI with contrast 1 area (Paediatric age 6 to 18) | £329 |
Asked by: Tanmanjeet Singh Dhesi (Labour - Slough)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent steps has he taken to increase bowel screening uptake in Slough constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Improving cancer services is a priority for the Government. We will get the National Health Service diagnosing cancer earlier and treating it faster so that more patients survive, and we will improve patients’ experience across the system. Slough is seeing an improvement in bowel screening uptake, although this remains below the national average.
Commissioners and providers continue to work together to address this variation and to ensure that all eligible residents are supported to participate in screening at the earliest opportunity.
The Berkshire Bowel Cancer Screening Programme and local partners have undertaken several initiatives to increase awareness and participation in Slough including:
In addition, Slough Borough Council is actively supporting improvement in cancer screening uptake through communication and training measures.
All partners remain committed to collaborative working to reduce inequalities, strengthen pathways, and support increased uptake among underserved populations.